This inventor holds 4 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: H. Lundbeck A/s, Vernalis &r&d) Ltd.. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 513 
3 out of 68 
Years Active: 2016-2017
Title: Douglas Stewart Williamson: Innovator in LRRK2 Inhibitors
Introduction
Douglas Stewart Williamson is a notable inventor based in Winnersh, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target LRRK2, a protein associated with various neurodegenerative diseases.
Latest Patents
Williamson holds 4 patents, with his latest inventions focusing on arylpyrrolopyridine derived compounds as LRRK2 inhibitors. These compounds are designed to treat diseases linked to LRRK2, such as Lewy body dementia, Parkinson's disease, and certain types of cancer. The innovative derivatives of Formula A are considered promising in the ongoing battle against these debilitating conditions.
Career Highlights
Throughout his career, Williamson has worked with reputable companies, including H. Lundbeck A/S and Vernalis (R&D) Limited. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Williamson has collaborated with esteemed colleagues, including I-Jen Chen and Simon Bedford, contributing to the advancement of research in his field.
Conclusion
Douglas Stewart Williamson's work in developing LRRK2 inhibitors showcases his commitment to addressing critical health challenges. His innovative approach and collaboration with industry leaders highlight the importance of continued research in the pharmaceutical sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile